Princess Private Equity Holding (GB:PEY) has released an update.
Partners Group Private Equity Ltd reported a 0.5% increase in NAV for September, reaching EUR 14.24 per share, driven largely by KinderCare’s IPO. The company invested EUR 6.7 million, notably in FairJourney Biologics, a leading CRO, and received distributions of EUR 6.3 million, primarily from selling a stake in Galderma to L’Oréal. These strategic moves aim to bolster growth and capital returns in the evolving private equity landscape.
For further insights into GB:PEY stock, check out TipRanks’ Stock Analysis page.
